Surrogate biomarkers of outcome for wake-up ischemic stroke

BACKGROUND: Wake-up ischemic stroke (IS) has been usually excluded from acute stroke therapy options for being outside of the safe treatment window. We identified risk factors, and clinical or molecular biomarkers that could be therapeutic targets for wake-up stroke prevention, thus hopefully leadin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hervella, Pablo, Alonso-Alonso, María Luz, Pérez-Mato, María, Rodríguez-Yáñez, Manuel, Arias-Rivas, Susana, López-Dequidt, Iria, Pumar, José M., Sobrino, Tomás, Campos, Francisco, Castillo, José, Iglesias-Rey, Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178818/
https://www.ncbi.nlm.nih.gov/pubmed/35681147
http://dx.doi.org/10.1186/s12883-022-02740-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178818/
https://www.ncbi.nlm.nih.gov/pubmed/35681147
http://dx.doi.org/10.1186/s12883-022-02740-z

Ejemplares similares